April 2018
« Back to 2018
_awards_Dal-led_project_$3.2_million_to_develop_new_immunotherapy_drugs_for_advanced_melanoma/_jcr_content/contentPar/newsArticle/image.adaptive.140.high.jpg/1526316660997.jpg "U.S. National Institutes of Health (NIH) awards Dal‑led project $3.2 million to develop new immunotherapy drugs for advanced melanoma")
–
News
Saturday, April 28, 2018
The AFMC and Dalhousie University Faculty of Medicine dedicated a Board meeting to hear from leaders and learners about student and physician burnout.
Dr. Thomas J. Marrie has crafted a truly illustrious career as a medical researcher, teacher, administrator and clinician.
Dr. Michelle Mujoomdar completed her PhD in pharmacology at Dalhousie and joined CADTH in 2008.
–
News
Friday, April 13, 2018
Dr. Ashley P. Miller is one of a select group of authors of a series for UK-based The Lancet.
Dalhousie Medical Research Foundation is launching a new spring Molly Appeal to raise funds for a vital piece of equipment
–
News
Thursday, April 12, 2018
IMPART team comprised of DMNB faculty members pitches purchase of Nobel-prize winning super-resolution microscope to the Dragons - the first of its kind in Canada dedicated to clinical research.
Five researchers from Dalhousie are receiving new funding to acquire the cutting-edge tools needed to conduct world-class research through the Canada Foundation for Innovation's John R. Evans Leaders Fund.
A Dalhousie Medical School cancer immunologist has received a rare five-year operating grant.